3-24 | A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more patient data was extremely unlikely to change the trial’s outcome.
7-6 | 120,707 people signed petitions urging the corporation to drop the price.
6-9 | COVID-19 has affected millions all over the world. Like many other organisations responding to the pandemic, Doctors Without Borders/Médecins Sans Frontières (MSF) is faced with challenges—from the global shortage of PPEs to lack of transportation. Despite these obstacles, MSF finds ways to care for the most vulnerable: children, refugees, people living with HIV, high-risk groups, and more.
5-9 | The only European country facing an armed conflict, Ukraine's healthcare system was already under great strain, especially in the east where sporadic hostilities have left many struggling to access healthcare. The spread of COVID-19 threatens to further overwhelm the country's healthcare capacity.
6-12 | Médecins Sans Frontières (MSF) released findings from a follow-up survey of its community-based HIV/TB project in Eshowe, KwaZulu Natal.